Probiotics Market Size, Share, and Growth Analysis Through 2027

Probiotics Market Size, Share, and Growth Analysis Through 2027 The global probiotics market was valued at USD 48.88 billion in 2019 and is expected to reach USD 94.48 billion by 2027, reflecting a CAGR of 7.9% over the forecast period. North America held a 16.98% share of the market in 2019. In the U.S., the sector is projected to witness substantial expansion, with estimates suggesting it could reach USD 17.99 billion by 2032, supported by rising consumption of probiotics-enriched and immunity-boosting foods due to their recognized health benefits. Growing preventive healthcare and the demand for safe, natural, and health-enhancing products are anticipated to fuel market growth. Supportive initiatives from professional associations and industry bodies are further promoting probiotics adoption. For example, the Nutrition Society of Malaysia (NSM) launched the consumer awareness of Probiotics Education Program (PEP) to better inform consumers about the product s health-promoting properties. Information Source: https://www.fortunebusinessinsights.com/industry- reports/probiotics-market-100083 Rising Demand for Immunity-Boosting Products Amid COVID-19 The COVID-19 outbreak caused short-term disruptions in supply chains and the global economy. However, demand for functional and immune-supportive products surged during this period as consumers became more mindful of health and nutrition. Probiotics, known for supporting digestive wellness and immunity, experienced increased interest, and this trend is expected to continue. Several companies reported notable growth during the pandemic. For instance, in April 2020, Probi a leading global probiotics brand saw a sharp increase in demand as consumers actively sought immunity-enhancing solutions. This consumer behavior is likely to remain strong even beyond the pandemic. Report Scope

This report delivers a comprehensive analysis of the probiotics market, including key drivers, restraints, opportunities, and challenges. It also examines regional dynamics, global industry trends, and strategies adopted by leading players. The study further covers significant market activities such as product launches, mergers, acquisitions, and partnerships recorded between 2020 and 2027. Key Growth Drivers According to the World Health Organization (WHO), global obesity rates have nearly tripled since 1975, with related chronic conditions such as obesity and diabetes becoming increasingly prevalent. This has driven consumers toward healthier diets and functional foods, boosting demand for probiotic products for their digestive and immunity benefits. In addition, advancements in technology are enabling companies to better educate consumers, thereby accelerating product adoption. Market Segmentation Highlights In 2019, supermarkets and hypermarkets dominated probiotic distribution, accounting for 61.33% of sales, largely due to their wide product selection, promotional offers, and consumer accessibility. Regional Insights Asia-Pacific continues to be the leading region in the probiotics market, supported by the long-standing cultural consumption of fermented foods and beverages that naturally aid digestive health. North America, valued at USD 8.30 billion in 2019, is forecasted to grow considerably between 2020 and 2027, driven by the increasing incidence of chronic diseases and greater investment in innovative probiotic solutions. Competitive Landscape Leading players are prioritizing research and development, product innovation, and expansion strategies such as partnerships, collaborations, and acquisitions. These efforts aim to broaden global reach and enhance distribution networks. Prominent Market Players Include: Danone S.A. (France) Lallemand Inc. (Canada) Yakult Honsha Co., Ltd. (Japan) Nestl S.A. (Switzerland)

DuPont (Danisco A/S) (USA) Chr. Hansen (Denmark) Kerry Inc. (Ireland) Post Holdings, Inc. (USA) PepsiCo, Inc. (USA) Evolve Biosystems, Inc. (USA) Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample- pdf/probiotics-market-100083 Recent Development June 2020: Pendulum Therapeutics introduced Pendulum Glucose Control, a clinically proven medical probiotic designed to reduce postprandial blood sugar levels and A1C, representing a breakthrough innovation in probiotics for managing metabolic health.